BACKGROUND: Molecular magnetic resonance imaging is a promising modality for the characterization of abdominal aortic aneurysms (AAAs). The combination of different molecular imaging biomarkers may improve the assessment of the risk of rupture. This study investigates the feasibility of imaging inflammatory activity and extracellular matrix degradation by concurrent dual-probe molecular magnetic resonance imaging in an AAA mouse model.
A
bdominal aortic aneurysms (AAAs) are the third leading cause of death after myocardial infarction and stroke in the group of cardiovascular diseases. 1 The incidence of AAAs has been continuously increasing, currently occurring in 3% to 4% of men aged over 65 years. 2 Although there are several causes leading to aneurysm formation, including trauma or connective-tissue diseases, most AAAs are still categorized as nonspecific. 2 Regardless of the cause, progressive dilatation of the aortic wall can result in AAA rupture, with a mortality rate of >90%. 3 Formation, progression, and rupture of AAAs involve 2 key processes, which are inseparably connected: inflammation and extracellular matrix (ECM) degradation, including the breakdown of elastic fibers. Both processes represent a key factor for the clinical outcome of AAAs. 4 During the initial phase of aortic aneurysm development, proinflammatory cells accumulate within the medial wall and produce cytokines and proteases leading to degradation and dilatation of the aortic wall. 5 The breakdown of ECM proteins in the aortic wall, especially elastin and collagen, leads to an inability of the vessel wall to withstand the pulsating intraluminal pressure. 4 The stronger the inflammatory process and the more pronounced the degradation of ECM proteins, the higher the probability of AAA rupture. 6 For the diagnosis of AAAs in clinical practice, CT, magnetic resonance imaging (MRI), or ultrasound-based angiographic techniques are still the reference standard. Besides aortic diameter, there is currently no established biomarker available for the evaluation of risk of aortic rupture. 2 In the past several years, molecular MRI has been successfully used for the visualization of proinflammatory cells and ECM proteins for the evaluation of AAAs. [7] [8] [9] [10] However, the merits of a combined assessment of inflammatory activity and ECM degradation in 1 MRI examination has not been evaluated to date.
The aim of the present study was to test the feasibility and predictive value of concurrent multitarget dualprobe molecular MRI for the in vivo characterization of AAAs in an experimental mouse model. Iron oxide particles were used for the visualization of the inflammatory activity, whereas an elastin-specific gadoliniumbased probe was used to visualize ECM degradation.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request.
Animal Experiments
All procedures were performed according to the guidelines and regulations of the Federation of Laboratory Animal Science Associations and the local Guidelines and Provisions for Implementation of the Animal Welfare Act. Male ApoEknockout (B6.129P2-ApoE tm1Unc /J) were obtained from the Research Institute of Experimental Medicine at the Charité Berlin. For aneurysm induction, osmotic minipumps (Alzet model 2004, Durect Corp) were implanted subcutaneously in the dorsal neck region at the age of 8 weeks (n=36). For up to 28 days, Ang II (angiotensin II) was continuously infused with a rate of 1000 ng/(kg·min). Sham-operated ApoE −/− mice (n=9) delivered saline over a course of 28 days, serving as the control group. In group 1 (longitudinal study, n=13), the first day of imaging included imaging before and after the administration of 0.2 mmol/kg of an elastin-specific contrast agent. After the second magnetic resonance (MR) scan, a clinical dose (4 mg Fe/kg) of ferumoxytol was administered. After 24 hours, MRI was repeated, including imaging before and after the administration of 0.2 mmol/kg of an elastin-specific contrast agent; Figure 1A ). Animals were then followed up for 4 weeks with death as end point to evaluate the potential of both probes for the prediction of aneurysm rupture. In group 2 (week-by-week study), imaging was performed after 1, 2, 3, and 4 weeks (n=9 per group) of Ang II infusion after administration of both probes ( Figure 1B ). Ex vivo analysis (histology, immunohistochemistry, inductively coupled mass spectroscopy (ICP-MS), and laser ablation coupled to inductively coupled plasma-mass spectrometry) was performed after the final scan of each week (n=9 per week) to correlate in vivo with ex vivo results. As control, 9 ApoE −/− mice were implanted with osmotic minipumps primed with sodium chloride. Please refer to the Data Supplement for further details.
CLINICAL PERSPECTIVE
Abdominal aortic aneurysms (AAAs) are the third leading cause of death after myocardial infarction and stroke in the group of cardiovascular diseases. The incidence of AAAs has been continuously increasing, currently occurring in 3% to 4% of men aged over 65 years. Although there are several causes leading to aneurysm formation, including trauma or connective-tissue diseases, most AAAs are still categorized as nonspecific. Regardless of the cause, progressive dilatation of the aortic wall can result in AAA rupture, with a mortality rate of >90%. Molecular magnetic resonance imaging is a promising modality for the characterization of AAAs. The combination of different molecular imaging biomarkers may improve the assessment of the risk of rupture. This study demonstrates the potential of the concurrent assessment of inflammatory activity and extracellular matrix degradation by dual-probe molecular magnetic resonance imaging in an experimental mouse model of AAA. Based on the combined information from both molecular probes the rupture of AAAs could reliably be predicted, with higher accuracy compared with each probe alone. The combined in vivo quantification of these biomarkers in 1 imaging session may be useful to improve the in vivo characterization of AAAs.
Gadolinium-Based Elastin-Specific Contrast Agent
The elastin-specific probe (ESMA; Lantheus Medical Imaging, North Billerica, MA) is composed of the D-amino-acid homophenylalanine, which is linked to a gadolinium-diethylenetriaminepentaacetic acid complex. 11, 12 Ex vivo measurements obtained a longitudinal relaxivity for the agent bound to mice aortas of 8.65±0.42 mmol/L −1 s −1 at 3 T. 11 This probe has already been introduced in different previous studies in the context of aortic aneurysm, 7, 10, 13 as well as atherosclerosis. 11, 12 In this study, a clinical dose of 0.2 mmol/kg was used and administered via the tail vein on day 1 and 2 of MR imaging.
Iron Oxide-Based Macrophage-Specific Agent
Iron oxide particles lead to a strong decrease in T1 and T2/ T2* relaxation time and, therefore, to a signal void in the corresponding MR images.
14 In this study, we used ferumoxytol (Feraheme, AMAG Pharmaceuticals, Waltham, MA), an ultrasmall superparamagnetic iron oxide particle. 15 With a relative size of 30 nm, the iron particles are phagocytized by cells of the mononuclear phagocyte system. Ferumoxytol shows a prolonged blood-pool phase with a plasma half-life of 14 to 21 hours and delayed intracellular uptake.
14 Therefore, MR imaging was performed 24 hours after administration of a clinical dose (4 mg Fe/kg) via the tail vein.
In Vivo MR Experiments
For all imaging sessions, a clinical 3T Siemens system (Biograph, Siemens Healthcare Solutions, Erlangen, Germany) and a clinical approved single loop coil (47 mm) were used. For details on the T1-weighted and T2*-weighted sequences, please refer to the Data Supplement.
Assessment of MRI Signal

Assessment of the Gadolinium-Based ElastinSpecific Probe on T1-Weighted Sequences
All resulting MR images were analyzed using OsiriX (version 7.1, OsiriX foundation). Morphometric measurements were conducted on high-resolution MRI images. For signal measurements, regions-of-interest were defined as areas of signal enhancement, which were colocalized with areas of aneurysmal aortic tissue. For these areas, the contrast-to-noise ratio (CNR) was calculated as follows: CNR=(combined vessel wall and aneurysmal aortic tissue signal−blood signal) / SD signal (noise). Noise was defined as the SD in pixel intensity from a regionsof-interest placed in the background air anterior to the aorta.
Quantification of Iron Oxide on T2*-Weighted Sequences
The aortic aneurysm areas were assessed by comparison (subtraction) of precontrast T2*-weighted MR images before iron oxide injection and images 24 hours postinjection. Using identical window and level settings, the areas of signal void within the regions-of-interest (mm 2 ) were measured. Identical 2-dimensional segmentation parameters were used to establish areas semiautomatically.
Histological Analysis of Aortic Aneurysms and Aortic Aneurysm Morphometry
Histological analysis is provided in the Data Supplement.
Immunofluorescence Analysis
Immunofluorescence analysis is provided in the Data Supplement.
ICP-MS and Element Specific Bioimaging Using Laser Ablation Coupled to Inductively Coupled Plasma-Mass Spectrometry
ICP-MS and Element Specific Bioimaging is provided in the Data Supplement.
Competition Experiments
Details on competition experiments are provided in the Data Supplement.
Statistical Analysis
Values are specified as mean±SD. For the comparison of continuous variables, a Student t test (unpaired, 2-tailed) was applied. Sensitivities and specificities of imaging measurements were compared with survival data of the animals (the reference standard). Linear regression was applied to determine the relationship between in vivo and the ex vivo measurements. A P value <0.05 was considered to indicate a statistically significant difference.
RESULTS
For details on the study setup, please see Figure 1 . In sham-operated mice (n=9), which served as control group and received a continuous saline infusion for 28 days, AAA development was not observed (Figures 1 and 2 ).
Concurrent Molecular MRI of Inflammatory Activity and ECM Degradation for the Prediction of Aneurysm Rupture (Group 1, Longitudinal Group)
To evaluate the potential of multitarget MRI as a prognostic tool for aneurysm rupture, a longitudinal investigation of ApoE −/− mice was performed (group 1, longitudinal group, n=13). After 1 week of Ang II infusion, the administration of the iron oxide particles resulted in an 85% larger signal void on T2*-weighted images (P=0.004) in animals suffering subsequent deadly aneurysm rupture (n=4) compared with animals which survived (n=9; Figures 3A, 4A , and 4B). Based on the signal void resulting from the iron oxide particles, AAA rupture could be predicted with a sensitivity of 80%, a specificity of 89% (cutoff 0.565), and an area under the curve of 0.91 ( Figure 3B ). This finding suggests that the accumulation of proinflammatory macrophages within the aneurysmal wall represents a novel imaging biomarker for aneurysm rupture.
After 1 week of Ang II infusion, the elastin-specific MR probe in animals, which died of aneurysm rupture, showed an 84% lower CNR (P=0.03) on T1-weighted images compared with surviving animals ( Figures 3A,  4A, 4B ). Based on the signal from the elastin-specific probe, AAA rupture could be predicted with a sensitivity of 80%, a specificity of 78% (cutoff 0.59), and an area under the curve of 0.82 ( Figure 3C ). This observation suggests that the breakdown of elastic fibers within the aneurysmal wall also represents a novel imaging biomarker for aneurysm rupture.
The combined assessment of the iron oxide particles and elastin-specific probe demonstrated the highest accuracy for the prediction of aneurysm rupture with a sensitivity of 100%, a specificity of 89%, and an area under the curve of 0.99 ( Figure 3D ) compared with each parameter alone.
Concurrent Imaging of Inflammatory Activity and ECM Degradation for the Characterization of Different Stages of Aortic Aneurysms (Group 2, Week-byWeek Group)
Ang II infusion resulted in an average increase of 81% in the aortic diameter after 7 days, of 250% after 14 days and of 276% after 28 days ( Figure I in the Data Supplement).
In early-stage aneurysms, 1 week after Ang II infusion, the degradation of elastic laminae with an associated dissection of elastic fibers could be observed in vivo, using the elastin-specific probe and ex vivo with histology showing a dilation of the aortic lumen and the formation of an intramural hematoma in 70% of the mice. Simultaneously, an increasing MR signal void in the area of the aortic wall was observed based on the accumulation of the iron oxide particles and ex vivo histology. Between 2 and 3 weeks after Ang II infusion, further degradation of elastic fibers was observed, being associated with an additional increase in aortic diameter ( Figure 5A1-5A7) . Additionally, an increased inflammatory response was observed, which involved the infiltration of macrophages.
In late-stage aneurysms, 4 weeks after Ang II infusion, strong ECM remodeling at the rupture site was observed characterized by expression of elastic fibers in vivo and ex vivo ( Figure 5B1-5B7 ).
T2*-Weighted MR Imaging for the Assessment of Macrophage-Specific Iron Oxide Particles
Before the administration of the macrophage-specific iron oxide particles, a bright circular lumen was observed on cross-sectional T2*-weighted images of the abdominal aorta in all Ang II-infused and salineinfused mice. Twenty-four hours after ferumoxytol-injection, a significant MRI signal loss on T2* sequences could be observed in the aneurysmal aortic wall of mice treated with Ang II infusion ( Figure 5B3 ), whereas no significant MRI signal changes were found in control mice ( Figure 2A3 ). The area of MRI signal void was localized in the aneurysmal wall close to dissection site, and the area increased with AAA progression up to 4 weeks. In vivo MRI measurements showed a strong correlation with ex vivo analysis of Prussian blue-stained iron particles on histological sections (y=0.11x+0.17, R 2 =0.96; P<0.001, Figure IIA in the Data Supplement).
T1-Weighted MR Imaging for the Assessment of the Gadolinium-Based Elastin-Specific Probe
A low CNR was measured in the aortic wall on all MR scans before the administration of the elastin-specific probe in Ang II-infused and saline-infused mice. After the administration of the elastin-specific-agent, a significant increase (P<0.001) in CNR in the aneurysmal aortic wall was measured ( Figure 5B2 ). These findings correlated with ex vivo measurements of elastic fiber density on histological sections using the Elastica van Gieson staining (y=0.09x+5.37, R addition, 24 hours after the administration of the iron oxide particles, T2*-weighted-imaging was performed before and 45 minutes after the administration of the elastin-specific probe. Measurements on T2*-weighted images before and after the administration of the gadolinium-based probe showed a strong correlation (y=1.03x−0.01, R 2 =0.97; Figure IIIB in the Data Supplement) and no significant difference (P=0.88) between both time points.
Correlation of In Vivo Measurements of the Elastin-Specific Probe With Ex Vivo Histology
To investigate the spatial distribution of elastic fibers in aortic aneurysms, histological sections were stained with the Elastica van Giesson staining, and the percentage of elastic fibers in relation to the overall adventitial area was determined. Histological ex vivo measurements were in good correlation with in vivo T1-weighted MR sequences using the elastin-specific probe (y=0.09x+5.37; R 
Correlation of In Vivo Measurements of Iron Oxide Particles With Ex Vivo Histology and Immunohistochemistry
Immunofluorescence staining with an anti-CD68 monoclonal antibody as tissue macrophage marker was used to evaluate macrophage accumulation in the aneurysmal tissue ( Figure 5A7 and 5B7). Perls Prussian blue staining and CD68-staining of adjacent histological sections confirmed the colocalization of macrophages and iron oxide particles ( Figure IVA in the Data Supplement). A strong correlation was found between areas positive for CD68 and Prussian blue-stained areas in relation to the overall adventitial area (y=1.03x+0.80; R 2 =0.98; Figure IVB in the Data Supplement). Additionally, a strong correlation was measured between the area of signal void on in vivo T2* sequences after the administration of the A, In animals suffering from aortic rupture, MRI with both probes demonstrated an elevated macrophage activity (P=0.004) and significantly lower elastin content (P=0.03) of the aneurysmal wall compared with those surviving. B, Based on the MR signal void resulting from the iron oxide particles, abdominal aortic aneurysm (AAA) rupture could be predicted with a sensitivity of 80%, a specificity of 89%. C, Based on the signal from the elastin-specific probe, AAA rupture could be predicted with a sensitivity of 80%, a specificity of 78%. D, The combined assessment of both imaging probes demonstrated the highest accuracy for the prediction of aneurysm rupture with a sensitivity of 100%, a specificity of 89%. CNR indicates contrast-to-noise ratio.
iron oxide particles and the ex vivo Prussian blue stain (y=0.11+0.17, R 2 =0.96).
Gadolinium Concentration by ICP-MS
Measurements by ICP-MS were performed in 12 mice (n=3 mice per time point and n=3 control mice). In vivo CNR measurements correlated strongly with ex vivo measured gadolinium concentrations by ICP-MS ( Figure  IIC in the Data Supplement). Also, a significant correlation between in vivo T2* measurements and ex vivo measured iron ions content by ICP-MS was observed ( Figure IID in the Data Supplement).
Spatial Localization of the GadoliniumBased Elastin-Specific Probe and Iron Oxide Particles Using Laser Coupled Mass Spectrometry
The spatial distribution of gadolinium and iron ions within the aneurysmal wall was visualized using laser ablation coupled to inductively coupled plasma-mass 
Competition Experiments
The specific binding of the elastin probe was shown by an in vivo competition experiment in 3 mice (n=3) after 4 weeks of Ang II infusion. After the injection of a 10-fold higher dose of the nonparamagnetic europiumlabeled elastin-specific probe, a significant decrease of CNR was observed compared with the administration of the gadolinium-labeled elastin-specific agent alone Figure 6B ).
DISCUSSION
This study demonstrates the potential of the concurrent assessment of inflammatory activity and ECM degrada- . A2 and B2, Precontrast T1-weighted magnetic resonance (MR) scans show no relevant signal of the aortic aneurysm before the administration of the elastin-specific probe. A4 and B4, A bright circular lumen/aortic aneurysm can be observed before the administration of the iron oxide particles. A3 and B3, In the surviving animal (A4), a strong enhancement of the elastin-specific probe in the ruptured aortic wall is visualized, indicating only a minor breakdown of elastic fibers. In the animal, which suffered a fatal aneurysm rupture (B4), only a weak enhancement from the elastin-specific probe can be seen, indicating a pronounced breakdown of elastic fibers. A5 and B5, In the surviving animal (A5), a minor signal void resulting from the accumulation of iron oxide particles in the ruptured aortic wall is visualized. In the animal, which suffered a fatal aneurysm rupture (B5), a strong signal void resulting from the iron oxide particles is visualized, indicating a pronounced influx of proinflammatory macrophages. The black arrows highlight the fusion of the elastin and iron oxide MR images to indicate the spatial relation of the different processes to each other. The solid arrows indicate the signal from the elastin-specific probe; the dotted arrows indicate the signal void resulting from the accumulation of the iron oxide particles. AAA indicates abdominal aortic aneurysm; MRA, MR angiography; and TOF, time-of-flight.
tion by dual-probe molecular MRI in an experimental mouse model of AAA. Based on the combined information from both molecular probes, the rupture of AAAs could be reliably predicted, with higher accuracy compared with each probe alone. The concurrent in vivo quantification of these biomarkers in 1 imaging session could be useful to improve the in vivo characterization of AAAs.
Molecular MRI for the Characterization of Aortic Aneurysms
Even though the pathophysiology of AAAs is not fully elucidated yet, inflammation was shown to be a key process in AAA development. Especially, macrophages play a central role by secreting inflammatory cytokines and proteases, such as MMPs (matrix-metalloproteinases). 4 In this context, the degradation of the ECM is another key biological process for AAA progression, including the breakdown of cross-linked elastin and collagen. The loss of medial elastin fibers because of increased degradation by different enzymes is thought to be the initiating event of AAA development. 16 Ongoing elastin degradation leads to reduced stability of the aortic wall. 16 Inflammatory activity and ECM degradation represent promising in vivo biomarkers to improve the characterization of aneurysms and prediction of aortic rupture. Previous studies have shown that the application of the gadolinium-based elastin-specific probe, which was also used in the present study, allows the in vivo visualization of changes in elastin composition of the aortic wall at different stages of aortic aneurysms. 7, 17 Because of the shortening of the T1 relaxation times, gadolinium-based probes are visualized as a bright signal on T1-weighted sequences and can, therefore, be distinguished from iron oxide particles, which appear as signal void on T2/T2*-weighted sequences.
About iron oxide particles, several preclinical and clinical studies demonstrated the potential for imaging of macrophage activity in the aneurysmal wall. 9, 18 Especially the MA3RS study (MRI Using Ultrasound Superparamagnetic Particles of Iron Oxide to Predict Clinical Outcome in Patients Under Surveillance for Abdominal Aortic Aneurysms) demonstrated that iron oxide particle-enhanced MRI could identify aortic wall inflammation in patients with AAAs and predicts the rate of aneurysm growth and clinical outcome. 19 In the late phase (12-24 hours, uptake macrophages), iron oxide particles cause a local decrease in Figure 5 . In vivo dual-probe molecular magnetic resonance imaging (MRI) of inflammatory activity and extracellular matrix degradation during the development of aortic aneurysms (week-by-week-group). A1 and B1, Time-of-flight angiograms show the suprarenal abdominal aorta (aA), including the right renal artery (rRA), of a male ApoE −/− mouse after 2 wk (A1) and 4 wk (B1) of Ang II (angiotensin II) infusion. A2, On T1-weighted sequences, a weak signal enhancement resulting from the elastin-specific probe in the aneurysmal wall was observed after 2 wk of Ang II infusion. B2, After 4 wk of Ang II infusion, a strong remodeling of the rupture site by an expression of elastic fibers was observed in vivo by MRI after the administration of the elastin-specific probe. A3, Only a minor signal void resulting from the iron oxide particles on T2* sequences was be appreciated after 2 wk of Ang II infusion. B3, The most pronounced signal void was observed after 4 wk of Ang II infusion reflecting an increased macrophage infiltration into the aneurysmal wall (white dotted arrows). A4-A7 and B4-B7, Ex vivo histological measurements using Perls Prussian blue staining and immunofluorescence for macrophage accumulation confirmed the in vivo findings. The solid arrows indicate the signal from the elastin-specific magnetic resonance (MR) probe; the dotted arrows indicate the signal void resulting from the accumulation of the iron oxide particles. Scale bars represent 200 µm. *Area of the thrombus. EvG indicates Elastica van Gieson; HE, hematoxylin-eosin staining; MRA, magnetic resonance angiography; and TOF, arterial time-of-flight. T2/T2* relaxation time, which corresponds to a signal void in the MR images. In a clinical setting, patients with pronounced iron oxide particle accumulation within the aneurysmal wall, showed a 3-fold higher AAA growth rate compared with those with significantly lower particle uptake, despite having similar aneurysm diameters. 18 In contrast, in the early phase (blood-pool phase) iron oxide particles lead to a significant shortening of the T1 relaxation time and can, therefore, also be used for the visualization of the vascular system in this initial phase.
Concurrent Molecular MRI of Inflammatory Activity and ECM Degradation for the Prediction of Aneurysm Rupture
To our knowledge, this is the first study to show the feasibility of a dual-probe approach in a concurrent MR imaging session. In the present study, animals suffering subsequent deadly aneurysm rupture showed a significantly higher MR signal void in the aneurysm wall in vivo after 1 week of Ang II infusion compared with animals which survived. In our study, the iron oxide particles enabled the prediction of AAA rupture with a sensitivity of 80% and a specificity of 89%. This finding suggests that the accumulation of proinflammatory macrophages visualized by MRI within the aneurysmal wall represents a predictive marker for aneurysm rupture.
Regarding the ECM, after 1 week of Ang II infusion, a significantly stronger breakdown of elastic fibers in the aneurysmal wall was observed by MRI after 1 week of Ang II infusion in animals suffering subsequent deadly aneurysm rupture compared with animals which survived. The elastin-specific probe enabled the prediction of AAA rupture with a sensitivity of 80% and a specificity of 78%. This observation suggests that the breakdown of elastic fibers within the aneurysmal wall also represents a predictive imaging biomarker for aneurysm rupture.
Even though these 2 key processes, inflammatory activity, and ECM degradation are inseparably linked, they represent 2 independent processes during the development and potential rupture of AAAs. Although one process reflects the cellular component, the other comprises the ECM component of AAA development. If both processes overlap or occur simultaneously, the formation of aortic aneurysm is most likely. In this study, we could show that the combined assessment of both imaging probes demonstrated the highest accuracy for the prediction of aneurysm rupture with a sensitivity of 100% and a specificity of 89%. These findings underline that there is an additional and independent value of each parameter to the other and that the combined MR based assessment of both processes improves the risk of rupture prediction in AAAs.
Translational Potential of This Study
For a potential clinical application of concurrent imaging with 2 different MR probes in 1 imaging session, it is of high importance that there is no influence of the ironbased probe on the visualization and quantification of the gadolinium-based probe and vice versa. As part of this study, we could demonstrate that the iron oxidebased probe does not affect the visualization and quantification of the elastin-specific probe on T1-weighted scans. We could also show that the gadolinium-based probe does not affect the visualization and quantification of the iron oxide-based probe on T2*-weighted scans.
This study has further advantages in clinical translation. The iron oxide-based agent ferumoxytol is approved by the Food and Drug Administration for the treatment of iron deficiency anemia in adults and is currently used as an MRI agent in a clinical setting. Both agents in this study were administered at a clinical dose. Despite using an ultrahigh field preclinical MR scanner for small animals, imaging was performed using a clinical 3 T MR scanner. Therefore, relaxation, rotational correlation, and signal properties can be directly translated to human application. Additionally, molecular size and composition, as well as clearance of the gadoliniumbased probe, are comparable to contrast agents already used in clinical practice.
11
Mouse Model Used in This Study
The small animal model used in this study is one of the most commonly used AAA mouse models. In this model, AAAs develop spontaneously without the need for surgical intervention. The infusion of Ang II into male apoE-deficient mice leads to a reproducible formation of AAAs in the suprarenal region. 20 The formation of AAAs in this model recapitulates several facets of human disease including inflammation, thrombus formation, and rupture. 21 
Study Limitations
One main difference between human AAAs and those formed in Ang II-infused mice is that in ApoE −/− mice, AAAs develop in the suprarenal region. 6, 20 In addition, AAAs in human disease are generally not caused by dissection or intramural hematoma. Aortic dissections often lead on to the development of aneurysms, but the vast majority of AAAs have a different pathophysiology. Ferumoxytol is not clinically approved for the assessment of aortic aneurysms and has to be used off-label with care because of potential risk of complement activation. The elastin-specific agent is also not approved for clinical use. The safety profile of both agents in combination has to be investigated before this approach can be translated into a patient setting. Regarding the use of ferumoxytol, it is not fully elucidated whether iron oxide uptake in the spleen does induce inflammatory macrophages that are then recruited to the inflammatory site. It was also suggested that iron oxide particles can be used to increase the M1 to M2 ratio in cancers with potential therapeutic benefit. 22 These effects have to be thoroughly studied before a translation into a patient setting.
Conclusions
This study demonstrates the potential of the concurrent assessment of inflammatory activity and ECM degradation by dual-probe molecular MRI in an experimental mouse model of AAA. Based on the combined information from both molecular probes the rupture of AAAs could reliably be predicted, with higher accuracy compared with each probe alone. The combined in vivo quantification of these biomarkers in 1 imaging session may be useful to improve the in vivo characterization of AAAs.
